CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 40 filers reported holding CYTEIR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $131,075 | +111.3% | 46,153 | +93.5% | 0.00% | – |
Q2 2023 | $62,018 | +42.9% | 23,853 | 0.0% | 0.00% | – |
Q1 2023 | $43,412 | -44.8% | 23,853 | -50.0% | 0.00% | – |
Q4 2022 | $78,714 | +71.1% | 47,706 | +100.0% | 0.00% | – |
Q3 2022 | $46,000 | -35.2% | 23,853 | 0.0% | 0.00% | – |
Q2 2022 | $71,000 | -86.2% | 23,853 | -82.5% | 0.00% | – |
Q1 2022 | $515,000 | -60.5% | 136,510 | +18.9% | 0.00% | – |
Q4 2021 | $1,305,000 | -19.1% | 114,808 | +24.9% | 0.00% | – |
Q3 2021 | $1,613,000 | – | 91,891 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $4,476,421 | 8.93% |
Novo Holdings A/S | 3,940,413 | $112,892,832 | 7.45% |
BML Capital Management, LLC | 3,146,296 | $5,726,259 | 4.95% |
Newtyn Management, LLC | 952,947 | $1,734,364 | 0.34% |
Aldebaran Capital, LLC | 151,239 | $275,255 | 0.28% |
Avidity Partners Management LP | 1,764,100 | $3,210,662 | 0.11% |
Marquette Asset Management, LLC | 67,990 | $123,742 | 0.03% |
TANG CAPITAL MANAGEMENT LLC | 100,000 | $182,000 | 0.03% |
RBF Capital, LLC | 117,295 | $213,477 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 150,406 | $273,739 | 0.02% |